Archford Capital Strategies, LLC Johnson & Johnson Transaction History

Archford Capital Strategies, LLC

$681 Million
Q3 2024

A detailed history of Archford Capital Strategies, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 9,136 shares of JNJ stock, worth $1.41 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

9,136

Previous 9,536 4.19%

Holding current value

$1.41 Million

Previous $1.39 Million 6.25%

% of portfolio

0.22%

Previous 0.23%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$145.48 - $167.38 $58,191 - $66,952	-400 Reduced 4.19%	9,136 $1.48 Million
Q2 2024 Jul 17, 2024	SELL	$144.38 - $157.78 $506,918 - $553,965	-3,511 Reduced 26.91%	9,536 $1.39 Million
Q1 2024 Apr 24, 2024	SELL	$155.22 - $162.74 $83,042 - $87,065	-535 Reduced 3.94%	13,047 $2.06 Million
Q4 2023 Jan 12, 2024	SELL	$145.6 - $158.88 $97,552 - $106,449	-670 Reduced 4.7%	13,582 $2.13 Million
Q3 2023 Oct 27, 2023	BUY	$155.75 - $174.48 $186,121 - $208,503	1,195 Added 9.15%	14,252 $2.22 Million
Q2 2023 Aug 02, 2023	BUY	$154.35 - $166.11 $191,702 - $206,308	1,242 Added 10.51%	13,057 $2.16 Million
Q1 2023 Apr 18, 2023	BUY	$151.05 - $180.26 $254,670 - $303,918	1,686 Added 16.65%	11,815 $1.83 Million
Q4 2022 Jan 26, 2023	BUY	$160.2 - $179.79 $26,432 - $29,665	165 Added 1.66%	10,129 $0
Q3 2022 Oct 17, 2022	BUY	$161.33 - $179.52 $37,589 - $41,828	233 Added 2.39%	9,964 $1.63 Million
Q2 2022 Jul 12, 2022	BUY	$168.19 - $186.01 $10,764 - $11,904	64 Added 0.66%	9,731 $1.73 Million
Q1 2022 Apr 18, 2022	BUY	$158.14 - $179.59 $121,609 - $138,104	769 Added 8.64%	9,667 $1.72 Million
Q4 2021 Jan 20, 2022	BUY	$155.93 - $173.01 $84,825 - $94,117	544 Added 6.51%	8,898 $1.52 Million
Q3 2021 Oct 14, 2021	BUY	$161.5 - $179.47 $24,063 - $26,741	149 Added 1.82%	8,354 $1.35 Million
Q2 2021 Jul 23, 2021	SELL	$159.48 - $171.07 $78,304 - $83,995	-491 Reduced 5.65%	8,205 $1.35 Million
Q1 2021 Apr 26, 2021	SELL	$153.07 - $170.48 $2.04 Million - $2.28 Million	-13,349 Reduced 60.55%	8,696 $1.4 Million
Q4 2020 Jan 19, 2021	BUY	$137.11 - $157.38 $14,259 - $16,367	104 Added 0.47%	22,045 $3.53 Million
Q3 2020 Oct 19, 2020	BUY	$140.38 - $153.83 $364,005 - $398,881	2,593 Added 13.4%	21,941 $3.27 Million
Q2 2020 Jul 24, 2020	SELL	$128.81 - $155.51 $3,735 - $4,509	-29 Reduced 0.15%	19,348 $2.72 Million
Q1 2020 Apr 29, 2020	BUY	$111.14 - $153.99 $38,454 - $53,280	346 Added 1.82%	19,377 $2.54 Million
Q4 2019 Jan 15, 2020	SELL	$127.5 - $146.44 $10,072 - $11,568	-79 Reduced 0.41%	19,031 $2.78 Million
Q3 2019 Oct 23, 2019	SELL	$126.95 - $142.14 $366,504 - $410,358	-2,887 Reduced 13.12%	19,110 $2.47 Million
Q2 2019 Jul 18, 2019	BUY	$131.15 - $144.24 $289,972 - $318,914	2,211 Added 11.17%	21,997 $3.06 Million
Q1 2019 May 13, 2019	BUY	$125.72 - $139.79 $25,521 - $28,377	203 Added 1.04%	19,786 $2.77 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $342,600 - $412,325	2,789 Added 16.61%	19,583 $2.53 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $157,202 - $184,743	-1,293 Reduced 7.15%	16,794 $2.32 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $322,380 - $355,752	-2,700 Reduced 12.99%	18,087 $2.2 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $3,127 - $3,703	25 Added 0.12%	20,787 $2.9 Million
Q4 2017 Feb 16, 2018	SELL	$131.22 - $143.62 $214,544 - $234,818	-1,635 Reduced 7.3%	20,762 $2.9 Million
Q3 2017 Nov 17, 2017	SELL	$129.47 - $135.38 $128,304 - $134,161	-991 Reduced 4.24%	22,397 $2.91 Million
Q2 2017 Aug 25, 2017	SELL	N/A	-25 Reduced 0.11%	23,388 $3.09 Million
Q2 2017 Aug 18, 2017	BUY	N/A	21,177 Added 947.09%	23,413 $1.48 Million
Q2 2017 Aug 18, 2017	BUY	N/A	2,236	2,236 $198,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Account

Archford Capital Strategies, LLC Johnson & Johnson Transaction History